Home > News > Why biotech CEOs need to think like Steve Jobs
August 25th, 2007
Why biotech CEOs need to think like Steve Jobs
Abstract:
The company is engineering nanoscale particles that will deliver two drugs directly to the site of a tumor: One drug will shut down the blood vessels that feed the tumor while the other will deliver chemotherapy over a sustained period. By custom-building the package that will contain these two drugs, Tempo believes it can get the drugs to the right place -- and reduce side effects.
"Nanotechnology," Crane said, "has the potential to redefine drug therapy over the next five to 10 years."
Source:
boston.com
Bookmark:
| Related News Press |
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Leading the charge to better batteries February 28th, 2025
Quantum interference in molecule-surface collisions February 28th, 2025
New ocelot chip makes strides in quantum computing: Based on "cat qubits," the technology provides a new way to reduce quantum errors February 28th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||